SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-051211
Filing Date
2024-04-24
Accepted
2024-04-24 16:01:09
Documents
4
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242799-2_def14a.htm DEF 14A 767010
2 GRAPHIC lg_blackdiamond-4c.jpg GRAPHIC 13729
3 GRAPHIC px_24blackpxy01pg01-4c.jpg GRAPHIC 227000
4 GRAPHIC px_24blackpxy01pg02-bw.jpg GRAPHIC 208011
  Complete submission text file 0001104659-24-051211.txt   1331445
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39200 | Film No.: 24870484
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)